Stage IIIB Breast Cancer Recruiting Phase 2 Trials for Sargramostim (DB00020)

IndicationStatusPhase
DBCOND0028549 (Stage IIIB Breast Cancer)Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs